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Abstract 
Many studies report age as a risk factor for BoHV‑1 infection or seropositivity. However, it is unclear whether this 
pattern reflects true epidemiological causation or is a consequence of study design and other issues. Here, we seek 
to understand the age‑related dynamics of BoHV‑1 seroprevalence in seasonal calving Irish dairy herds and provide 
decision support for the design and implementation of effective BoHV‑1 testing strategies. We analysed seropreva‑
lence data from dairy herds taken during two Irish seroprevalence surveys conducted between 2010 and 2017. 
Age‑dependent seroprevalence profiles were constructed for herds that were seropositive and unvaccinated. Some 
of these profiles revealed a sudden increase in seroprevalence between adjacent age‑cohorts, from absent or low 
to close to 100% of seropositive animals. By coupling the outcome of our data analysis with simulation output of an 
individual‑based model at the herd scale, we have shown that these sudden increases are related to extensive virus 
circulation within a herd for a limited time, which may then subsequently remain latent over the following years. 
BoHV‑1 outbreaks in dairy cattle herds affect animals independent of age and lead to almost 100% seroconversion 
in all age groups, or at least in all animals within a single epidemiological unit. In the absence of circulating infection, 
there is a year‑on‑year increase in the age‑cohort at which seroprevalence changes from low to high. The findings of 
this study inform recommendations regarding testing regimes in the context of contingency planning or an eradica‑
tion programme in seasonal calving dairy herds.
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Introduction
Bovine Herpes Virus Type 1 (BoHV-1) is a highly con-
tagious virus of cattle and is known to be the causative 
agent of the acute respiratory disease infectious bovine 
rhinotracheitis (IBR). The virus occurs worldwide and is 
endemic in a number of food-producing countries [1]. 
Following infection, cattle are lifelong carriers of the 
virus with the potential of spontaneously reactivated 
viral shedding, especially at times of increased stress [2]. 
Infections with BoHV-1 may be associated with various 
clinical signs and changes in production parameters, 
ranging from fever, reduced growth rate and milk yield to 
an increased risk of abortion and death [3, 4].
When a naïve animal is exposed to BoHV-1, a so called 
primary infection can occur [2] and virus is excreted in 
nasal fluid over a period of 10–17  days with a peak at 
4–6  days post‐infection [5]. During the course of a pri-
mary infection, animals shed high levels of virus (up to 
3800 000  TCID50/mL nasal discharge; [6, 7]) and are con-
sidered the main spreaders of infection during an out-
break. In experimental studies, the number of secondary 
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cases generated by a single primary infected animal, the 
basic reproduction number (R0), is estimated between 
3.2 and 7 in herds with susceptible animals [8–11]. Fol-
lowing infection, cattle become latently infected. At this 
stage of infection, animals are virus carriers, seropositive, 
but neither shed infectious material nor exhibit clini-
cal signs. Usually, latently infected animals are identified 
by the detection of BHV-1-specific antibodies in their 
serum. Studies have shown that antibodies persist at 
stable levels in experimentally infected cattle for at least 
2–3  years [12]. BoHV-1 shedding can reactivate within 
latently infected animals (secondary infection), resulting 
in viral transmission and the establishment of primary 
infections in other naïve cattle [2].
A number of alternative pathways for BoHV-1 trans-
mission have been reported in the literature. Direct con-
tact between animals (e.g. nose to nose) is considered the 
most important route of transmission within farms [2]. 
Aerosol transmission can occur over short distances of 
up to five metres, and as such may result in between-herd 
transmission across farm boundaries [13]. However, the 
purchase of latently infected animals is considered to be 
the main source of between-herd spread.
Infections with BoHV-1 occur worldwide, although 
there are differences in prevalence and incidence [1]. 
In the European Union (EU), a number of countries 
or regions are considered free from BoHV-1 following 
the implementation of EU-approved eradication pro-
grammes [14], including Austria, Germany, Denmark, 
Finland, Sweden, Jersey (United Kingdom) and Valle 
d’Aosta and the Province of Bolzano (Italy) [15] and as 
such are granted additional guarantees in respect of 
trade to protect this status under Article 10 of Directive 
64/432/EEC. Switzerland and Norway are also considered 
free of infection, although they do not have formal Arti-
cle 10 status as non-EU members. Other countries and 
regions within the EU are currently implementing Com-
mission-approved eradication programmes, including 
Belgium, Czech Republic, Luxembourg and the province 
Friuli-Venezia Giulia in Italy [15] and are again granted 
additional guarantees in terms of trade under Article 9 
of Directive 64/432/EEC. In both cases, these additional 
guarantees impact on the trade of live cattle from coun-
tries or regions not free from BoHV-1, particularly when 
they do not have approved eradication programmes.
In the Republic of Ireland, information on BoHV-1 
prevalence is available from recent cross-sectional 
studies [16–19]. These studies indicate that BoHV-1 is 
endemic, with 75–90% of Irish herds positive for BoHV-1 
antibodies. Vaccination has been introduced to reduce 
herd prevalence. However, the legal use of non-marker 
vaccines ceased at the end of 2004. Since then, the only 
type of vaccine licensed in the Republic of Ireland are 
marker vaccines, allowing differentiation between field 
virus exposure and vaccination. A national programme to 
control BoHV-1 does not currently exist in Ireland, but is 
under active discussion, co-ordinated by Animal Health 
Ireland (AHI; www.anima lheal thire land.ie). The current 
study was undertaken to inform the consideration of 
options for a national eradication programme in Ireland.
An understanding of the dynamics of BoHV-1 sero-
prevalence within herds is essential to guide control 
decisions and inform programme design. The published 
literature contains a number of retrospective stud-
ies where age is repeatedly identified as a risk factor for 
BoHV-1 seropositivity [e.g. 10, 17, 19–22]. It is unclear 
whether this pattern reflects true epidemiological causa-
tion or is a consequence of study design. Moreover, an 
improved understanding of the dynamics of serological 
patterns in BoHV-1 positive herds is important as a basis 
for evaluating the effect of vaccination on within-herd 
seroprevalence.
The objectives of this study were (1) to understand 
the age-related dynamics of BoHV-1 seroprevalence in 
unvaccinated dairy herds with seasonal calving, and (2) 
to determine how vaccine usage affects these dynamic 




The data used for this study originated from two Irish 
seroprevalence studies undertaken by the Moorepark 
Animal and Grassland Research and Innovation Centre, 
managed by Teagasc (The Agriculture and Food Devel-
opment Authority), between the years 2010 and 2017. 
The data have already been used in previous studies and 
we refer to [23] for details of these BoHV-1 serological 
surveys.
In brief, the first seroprevalence study was carried out 
on 24 dairy herds from which blood samples were taken 
at least once between 2010 and 2013. Herds selected for 
the study were Teagasc research farms or participants 
in the Dairy Information System [24]. All antibody tests 
were performed using IDEXX ELISA test kits appropri-
ate to the vaccination status of the herd, i.e. using gE or 
gB tests. Antibody tests were classified as positive, nega-
tive or inconclusive based on the sample-to-positive ratio 
using cut-off thresholds in accordance with the manu-
facturer’s guidelines [23]. These data were supplemented 
by the results of additional bleeds of a subset of herds 
between 2015 and 2017. Information on the vaccination 
status of each herd was also collected, i.e. whether the 
herd was vaccinated or not, type of vaccine used and fre-
quency of vaccination.
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The second seroprevalence study was conducted in 
2015 on 57 dairy herds. Herds under investigation were 
members of a breeding information service (HerdPlus; 
https ://www.icbf.com/wp/?page_id=149), provided 
by the Irish Cattle Breeding Federation (ICBF). Blood 
samples were collected from the entire herd, tested for 
BoHV-1 antibodies and the herd´s vaccination status 
recorded. Information on the frequency of vaccination 
and the type of vaccine used were not recorded. Anti-
bodies were determined using IDVet gE and Qiagen gB 
ELISA in vaccinated and non-vaccinated herds, respec-
tively. Again, the sample-to-positive ratio was used for 
classifying antibody titres as positive, negative or incon-
clusive by referring to the manufacturer’s instructions.
Based on information provided by the manufactur-
ers, the test parameters for serological diagnosis ranged 
between 0.974 and 1 for sensitivity and 0.996 and 1 for 
specificity.
Merging both datasets resulted in 81 surveyed dairy 
herds with 23,459 individual BoHV-1 tests results.
Data processing & extraction of datasets
Data were managed in a Microsoft Access database and 
screened for errors and missing data. Analysis and visual-
ization was conducted entirely in R [25]. All animals with 
an inconclusive BoHV-1 antibody test result (n = 89) 
were removed from further analysis. Based on the herd 
number, movement data were extracted from the Animal 
Identification and Movement (AIM) database maintained 
by the national Department of Agriculture, Food and 
the Marine (DAFM). From January 2009 until Decem-
ber 2017, all in- and outward cattle movements per herd 
were matched with individual serology test data.
Herds were excluded from the dataset if the number 
of animals introduced each year was higher than 5% of 
the herd’s average size or the yearly out-moves exceeded 
50%. This is critical when analysing the dynamics of the 
within-herd seroprevalence (percentage of seroposi-
tive cattle in a herd) to ensure that potential increases/
decreases in prevalence are not dominated by moves into 
or out of each herd.
Based on the date of birth of each tested animal, we cal-
culated the age in days at the time of sampling. Animals 
were then grouped into age cohorts by year from 0 to 9. 
Animals older than 9 years were assigned to cohort > 9.
BoHV-1 seroprevalence was estimated at herd and age-
cohort level for each round of sampling, calculated as the 
number of seropositive cattle divided by the total number 
of cattle tested. For each age cohort, a Gaussian confi-
dence interval was calculated on the basis of the apparent 
prevalence of seropositive animals at the 95% significance 
level.
In a final step, we created two overlapping subsets of 
the data (A & B). Dataset A included serological results 
from herds that at the time of sampling were not vacci-
nated against BoHV-1. All herds that were seronegative 
or not completely sampled (e.g. missing young-stock 
data) were excluded. For herds that were tested mul-
tiple times the data of the first sampling was used. In 
dataset A, each herd was included only once. Thus 3994 
test results from 15 unvaccinated seropositive dairy 
herds were used for dataset A. Dataset B included all 
herds that were tested at least twice, irrespective of 
their vaccination status. All test results from these 
herds were included in dataset B, with the exception of 
results from herds that were not completely sampled 
for a given round of testing. 8972 test results from 13 
multiple-tested herds were retained in dataset B. These 
multiple tested herds were investigated to study the 
influence of vaccination on the within-herd prevalence. 
Six herds were already vaccinating before sampling was 
conducted or had started to vaccinate within the sam-
pling period. All herds in dataset B showed a decline 
in herd-level/age-related seroprevalence over time (see 
Additional file 3).
Modelling the spread of BoHV‑1 in dairy cattle
Model description
A stochastic, individual-based, herd-level simulation 
model of BoHV-1 infection was developed to demon-
strate the dynamics of age-dependent patterns of sero-
prevalence in BoHV-1 seropositive herds and provide a 
qualitative comparison with those of our serology data 
(Dataset A). The documentation of the model follows the 
ODD protocol (overview, design concepts, and details); 
[26–28] and is provided in the supplementary material 
(see Additional file 1).
The model simulates the spread of BoHV-1 in a sea-
sonal calving dairy herd, where young stock and lac-
tating cows are not epidemiologically separated and 
replacement stock are home-bred. The simulated herds 
are similar in structure (e.g. 120 breeding females) and 
management practices. The herds are simulated without 
in-moves and hence represent epidemiologically closed 
herds. The model simulations are not intended to repli-
cate the herds in the data but rather to highlight general 
BoHV-1 serology dynamics. The model design comprises 
two components [29]. The demographic component cap-
tures relevant biological and farming-related processes, 
and the pathogen-related component describes the trans-
mission and spread of BoHV-1 after the virus has been 
introduced. The simulation model runs in weekly time-
steps and is implemented in Scala (https ://www.scala 
-lang.org/).
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Modelled scenarios
We simulated 15 separate dairy herds, each for 20 years. 
BoHV-1 infection was seeded in all herds at the same 
point in time by infecting a random animal (seed 
infection).
In Scenario A, we simulated the course of infection in 
the herds while excluding reactivation of latently infected 
cattle. The serological status of each animal in the simu-
lated herd was recorded during the simulation period. 
The seroprevalence profiles across age-cohorts of the 
simulated herd were evaluated at three intervals: imme-
diately after infection (6 months after the initial seeding 
of infection); at a time point selected at random between 
years two and five, and at 12 years after the initial seeding 
of infection.
Scenario B was similar to A but this time a reactivation 
event was simulated 4.5 years after the initial seeding of 
infection. The reactivated individual was forced to infect 
one naïve animal, thereby triggering a primary infection 
during its infectious period. Again, three seropreva-
lence profiles were reported: at 6 months, at 5 years (i.e. 
6 months after the reactivation event), and at a time point 
selected at random between nine and 12 years after the 
initial seeding of infection (i.e. 4.5 to 7.5 years after the 
reactivation event).
Results
Within‑herd seroprevalence in unvaccinated dairy herds
Among the 17 unvaccinated dairy herds, two herds 
returned 100% negative test results. 15 dairy herds were 
non-negative (Dataset A) and within-herd seroprevalence 
varied between 0.8 and 96.2%. The overall seroprevalence 
in these 15 positive herds was 31.7% (SD 8%).
The overall seroprevalence of antibodies against 
BoHV-1 in these herds increased with age (Figure  1). 
The overall proportion of seropositive animals was low 
(< 20%) in younger animals (0–2 years), increasing in cat-
tle aged between two and five years old (from approxi-
mately 20% to 70%). In all older cohorts, the overall 
proportion of seropositive animals was approximately 
70%.
Figure  2 reassembles the data used in Figure  1, how-
ever, instead of summarizing data across the herds, the 
age-dependent seroprevalence profiles were plotted 
separately for each herd. The individual age-dependent 
seroprevalence profiles differed from each other. Three 
main patterns were observed, which suggests three dif-
ferent herd categories. The first category includes herds 
showing a very high prevalence throughout all age 
cohorts (red lines; two herds out of 15). In these herds, an 
increase in seroprevalence with age was not obvious. The 
second category of herd profiles has very low seropreva-
lence across all age cohorts (green lines; seven herds out 
of 15); again, no increase by age-cohort was seen. The last 
category of prevalence profiles includes those herds in 
which seroprevalence changes abruptly from low to high, 
typically between consecutive age cohorts (blue lines; six 
herds out of 15). The age cohorts in which this step-like 
increase occurred was variable, here ranging from 2–3 to 
5–6 years.
Outputs presented in Figures 1 and 2 show patterns of 





























Figure 1 Animal‑level seroprevalence in 15 unvaccinated seropositive dairy herds (Dataset A), by age cohort. Per age cohort the dataset 
is shown as the absolute number of seropositive/negative cattle (yellow/blue bar chart, left y‑axis); and as a proportion of seropositive animals (red 
line, right axis, with its 95% confidence interval). Red dots (right axis) refer to herd‑level seroprevalence for each herd, again by age‑cohort. (Note: 
Across the early and late age‑cohorts the individual herds’ prevalence values (red dots) tend to dichotomies between zero and 100%).
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was excluded. In practice many herds will not be closed 
(i.e. through homebred replacement) with movements 
both into and out of the herd over several age-cohorts. 
As a consequence, the age-dependent seroprevalence 
profiles may become noisier. Figure 3 presents an exam-
ple herd and provides a picture of how in-moves can 
mask the critical step-like increase in the age-dependent 
seroprevalence profile of the herd. This example herd 
was initially excluded from further analysis due to the 
large number of in-moves into this herd. Without the 
exclusion of purchased animals, almost all of which were 
younger than 6–7 years of age, the steep increase in sero-
prevalence between consecutive age-cohorts at 6–7 years 
was not evident (Figure  3A). Exclusion of introduced 
animals from the calculation of the age-dependent sero-
prevalence profile makes the critical age-related thresh-
old visible (Figure 3B).
Modelling BoHV‑1 within‑herd spread
Results from the individual herd-based simulation model 
are presented in Figure 4. With scenario A (no reactiva-
tion; Figure 4A), the simulated age-dependent seropreva-
lence profiles show similar patterns to those observed 
in the field data. No age-dependent trend is apparent 
in the seroprevalence profiles of the 15 individual herds 























Figure 2 Individual age‑dependent seroprevalence profiles of 15 unvaccinated seropositive dairy herds (Dataset A as in Figure 1). 
Each line represents the age‑dependent data from a single herd. Three qualitatively different profile categories are identified: [1] herds with a high 
seroprevalence throughout all age cohorts (red), [2] herds with one abrupt increase in seroprevalence between consecutive age cohorts (blue), 

















































Figure 3 Serological profile of a single unvaccinated herd before (A) and after (B) exclusion of purchased animals. Correction for 
movement events reveals the category of seroprevalence profiles reflecting the history of BoHV‑1 circulation in this herd. Note: Nevertheless, this 
herd was excluded from further analysis due to the high number of in‑moves.
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In the simulated herds, nearly all stock had seroconverted 
within half a year. A step change in seroprevalence from 
low to high between consecutive age-cohorts is observed 
in the subsequent seroprevalence profiles at time points 
scheduled at random between two and 5 years after the 
initial seeding of infection (blue lines). In this model-
ling scenario, reactivation was completely suppressed; 
therefore circulation of virus will reduce over time and 
animals born later (i.e. younger age-cohorts) are not 
exposed to infection. The last seroprevalence profiles are 
taken 12 years after the initial seeding of infection (green 
line). These profiles were nearly free of BoHV-1 seroposi-
tive animals due to the ongoing replacement of animals 
during normal management processes. Further, viral 
fade-out has already removed the majority of seroposi-
tive cattle that were infected during the original period of 
virus circulation. Only animals surviving into the oldest 
age-cohort (> 9y) remain in this profile.
In scenario B (Figure 4B), a reactivation event was trig-
gered four and half years after initial virus introduction, 
leading to new primary infections in naïve animals. At 
the point when reactivation occurred, a proportion of 
seropositive animals, i.e. older animals which had sero-
converted following the first period of extensive virus 
circulation 5  years previously, were still present in the 
simulated herds. However, the new primary infections 
caused another major episode of virus circulation and 
hence seropositivity was again high in all age-cohorts 
at the time of testing 6  months after reactivation (blue 
lines; 5  years after the initial introduction of infection). 
Comparing the individual age-dependent seroprevalence 
profiles (red vs. blue), it is not possible to distinguish 
age-related serological outcome between “subsequent” 
outbreaks induced by reactivation (blue lines) and “ini-
tial” outbreaks due to introduction into a naïve herd (red 
lines). Moreover, it is not possible to distinguish age-
dependent serology profiles more than 5 years after reac-
tivation (Figure 4B; green lines) with those up to 5 years 
after naïve introduction (Figure  4A; blue lines). There-
fore, at the level of age-dependent seroprevalence profiles 
in individual herds, any new period of virus circula-
tion effectively acts like a resetting of the clock. The key 
information provided by analysis of these herd profiles 
is the period of time during which the herd was free of 
circulating infection, as indicated by the absence of new 
seroconversions. This time interval is equivalent to the 
age-cohort in which the step increases occur, as shown 
in Figure 2.
Effect of vaccination on the within‑herd prevalence
With the intention of understanding how vaccination 
might affect herd-level seroprevalence, we selected a sin-
gle case herd from dataset B and analysed the change of 
age-dependent prevalence under vaccination over time 
(Figure  5). This herd was selected as it had the largest 
number of sample points. From the beginning of 2009 
until the end of 2017, this herd did not purchase any cat-
tle and can thus be considered as closed. In 2010 (Fig-
ure. 5A), the selected herd was non-vaccinating and was 
seronegative except for a few individuals in older age 
cohorts. One year later, in 2011 (Figure 5B) almost every 
animal in the herd had seroconverted as a result of active 
virus circulation. A vaccination programme was initiated 














































Time passed after 
introduction of infection
Figure 4 Model output of the age‑dependent seroprevalence profiles of 15 simulated cattle herds at three subsequent time points 
after a single introduction of BoHV‑1 infection (line colours). Solid lines represent individual herds, while dashed lines indicate the maximum/
minimum envelopes per time point. A Output scenario A—no reactivation: the 15 seroprevalence profiles are reported at 0.5 years (red); at a 
random time point between 2 and 5 years (blue); and at 12 years (green) after the initial seeding of infection. B Output scenario B—reactivation of 
a latent animal was forced 4.5 years after the initial seeding of infection, leading to an additional round of primary infection: the 15 seroprevalence 
profiles are reported at 0.5 years (red); at 5 years (blue); and at a random time point between 9 and 12 years (green) after the initial seeding of 
infection. Note: In (b) Blue lines, i.e. 5 years post introduction, equal 0.5 years after reactivation occurred; and green equals time points selected at 
random between 4.5 and 7.5 years after the reactivation event.
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circulation occurred in the herd since then (Figure  5C 
and D). Replacement of older seropositive stock by seron-
egative home-bred young-stock led to the expected shift 
in the age-dependent seroprevalence profile. In Figure 5D 
the critical jump occurred between age-cohorts 3–4 and 
4–5 (born in the spring of 2012 and 2011 respectively). 
Hence, the stock born during these three “preceding” 
years, beginning in 2012 and corresponding to the 3 years 
since vaccination was introduced remained free of infec-
tion, i.e. absence of spread of infection. Consistent with 
this, the most recent seroconversions in Figure 5D were 
found in age-cohort 4–5 i.e. the animals from age-cohort 
0–1 in 2011 when the major outbreak had occurred (5b). 
A similar pattern was also evident in the other vaccinat-
ing herds with minimal purchases (see Additional file 3).
Discussion
Age‑dependent patterns of BoHV‑1
Understanding the age-dependent patterns of BoHV-1 
spread is essential to accurately interpret trends in sero-
logical data and to inform decision-making in the context 
of the design and evaluation of control strategies such as 
vaccination. To our knowledge, this work is the first to 
explicitly explore the relationship between age-related 
serological profiles in seasonal calving dairy herds and 
BoHV-1 infection dynamics. The purpose of doing so 
was to improve the interpretation of surveillance outputs 
based on seroprevalence figures.
In this study we confirmed that, in herds with positive 
serological profiles, older cattle most commonly have 
antibodies against BoHV-1 (Figure  1). This is consist-
ent with other studies [e.g. 10, 17, 19–22], and would 
seem to concur with earlier suggestions of increased 
infection risk with age, or with age as a proxy measure 
of exposure time in combination with lifelong sero-
positivity. However, we caution against this conclusion. 
Indeed, the inspection of individual herd-level sero-
prevalence profiles highlights the pitfall of this inter-
pretation which is derived from analyses conducted 
on aggregated data. As demonstrated in Figure 2, there 
are no examples in any of the 15 unvaccinated dairy 
herds of a smooth increase in seroprevalence over sev-
eral age-cohorts to saturation level. In fact there are 
only two distinct situations of equivalent levels of sero-
prevalence (either low (< 20%) or high (> 80%)) across 
all age-cohorts. These findings are consistent with the 
literature; if BoHV-1 is actively circulating within a 
naïve herd, most animals will seroconvert within a 
short period of time [e.g. 9, 10, 29, 30]. These major 
outbreaks are a result of the high level of infectiousness 
of the virus. Different field studies have estimated the 
reproduction number (R0) of the infection between 3.2 
and 7 in unvaccinated herds [8–11].
The sudden increase in seroprevalence between con-
secutive age-cohorts that is observed in the individual 
herd-level profiles (Figure  2) reflects extensive viral cir-
culation within a herd for a limited time, which may then 
remain latent over the following years [10]. Several stud-
ies report extended periods of time with no evidence of 
BoHV-1 circulation in endemically infected herds [31, 
32]. Following a fade-out in virus circulation, subsequent 
(i.e. younger) age-cohorts in the herd can only sero-
convert following either introduction of new, actively 
infected animals into the herd or reactivation of latently 
infected animals leading to new primary infections. In 
our data, termination of virus circulation was evident, 
namely in the herds characterized by the abrupt increases 
in the seroprevalence profiles (Figure  2, blue lines). In 
these herds, virus circulation stopped between three and 
5  years before serological sampling i.e. the age cohort 
where the abrupt increase in seroprevalence occurred. 
The observed pattern is particularly evident in seasonal-
calving dairy herds in Ireland, where the (home-bred) 
population increases in a step-wise fashion and not con-
tinually over the year. However, model simulations relax-
ing the assumptions of seasonal calving did reveal the 
same feature of a sudden increase stretched over more 

















































































A B C D
Figure 5 Stacked area graphs representing the age‑dependent seroprevalence profile over a five year period in a single vaccinated dairy 
herd. The herd was serologically sampled in (A) 2010, (B) 2011, (C) 2013 and (D) 2015. In this herd, vaccination started in 2012. The left y‑axis (the 
number of animals) refers to the smoothed histograms (seropositive, seronegative) and the right y‑axis (seroprevalence) to the coloured line. The 
lines represent age‑dependent seroprevalence profiles, which were coloured according to the epidemiological stages as outlined in Figure 2.
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Bull breeding might cause a potential seroprevalence 
jump at age cohort 1–2 i.e. first breeding of naive heif-
ers [33]. And, by every years breeding season the infected 
bull potentially might cause successive age-cohorts with 
high seroprevalence. However, in our data set this is not 
the case because (1) not all “jumps” occur at age 1–2 so 
respiratory spread must have been involved, (2) infec-
tion by bull would either create single age cohorts with 
high sero-prevalence in those years when naive heifers 
got infected or subsequent reactivations may have caused 
respiratory spread affecting all cattle on herd that time, 
(3) artificial insemination (AI) has become the breeding 
norm on the majority of dairy farms in the Republic of 
Ireland.
The pitfalls of aggregated analysis (Figure 1) are related 
to the fact that herds usually are serologically sampled at 
different epidemiological stages relative to the time when 
virus was actively circulating (Figure 2). Aggregated herd 
sampling, essentially an averaging across age-cohorts, 
leads to a blurring of the temporal stage and a mislead-
ing interpretation of the age-related seroprevalence data 
(Figure  1). It is therefore not surprising that, in some 
studies where aggregated data are used, older animals are 
reported as being at higher risk of BoHV-1 infection due 
to time in the herd [21].
The three categories of herd-based seroprevalence 
profiles, as presented in Figure 2, were derived post hoc 
based on patterns observed in the data. The simulation 
modelling revealed that the course of a BoHV-1 outbreak 
in a naïve herd, together with different sampling times 
during that outbreak history, mirror the categories iden-
tified from the data (Figure 4A). Prior to testing of herds, 
their temporal stage relative to fade-off in infection cir-
culation (or introduction) is usually unknown. Therefore, 
for BoHV-1 survey data as described here, the number of 
herds in each of the three categories as well as the actual 
age-cohort with sudden increase of seroprevalence are a 
chance outcome. A summary of age-related seropreva-
lence across herds likely will, as an artefact, show the 
smooth increase of seroprevalence with age, as illustrated 
in Figure 1. This issue could be tackled by adjusting the 
individual seroprevalence profiles according to the age-
cohort in which infection faded out, i.e. where the jump 
occurs between consecutive age-cohorts.
Finally, we need to understand whether reactivation 
may lead to a pattern of gradual increase in age-related 
seroprevalence profiles similar to that presented in Fig-
ure  1, i.e. we may speculate that a low reactivation rate 
in combination with a low infectiousness of animals fol-
lowing reactivation of latent infection is leading to lim-
ited exposure in younger age-cohorts and hence lower 
seroprevalence estimates in these age-cohorts. To the 
authors’ knowledge, the rate at which reactivation occurs 
in latently infected animals has not yet been determined 
experimentally. However, previous modelling studies 
assumed that the rate at which the virus is reactivated in 
latently infected animals lies between 0.13 and 2.6% per 
year [34–36]. Following reactivation of latent infection, 
animals have been shown in experimental studies to shed 
on average 6000 times less infectious virus than animals 
undergoing primary infection [6, 37]. Hence, the infec-
tion risk posed following reactivation of latent infection 
is much lower than with primary infection. Despite this, 
the literature includes studies where reactivation of latent 
infection in single animals induced major virus outbreaks 
[8]. This is plausible given that reactivation can result in 
‘additional seroconversions’ if new primary infections are 
triggered, e.g. in the younger age-cohorts.
In our individual-based model (Figure  4B), the syn-
thetic reactivation event did result in a primary infection 
and always triggered substantial viral circulation, even if 
the herd already had a substantial proportion of seroposi-
tive animals, i.e. in the older cohorts. Hence, the scenario 
whereby reactivation establishes a primary infection can-
not result in a gradual increase in serological profiles by 
age. Therefore, age should not be reported as a risk fac-
tor in relation to IBR or BoHV-1 infection. Neverthe-
less, a randomly selected older animal is more likely to 
be tested seropositive for BoHV-1 antibodies than a ran-
domly selected young animal. On average, when consid-
ering aggregated data across multiple herds, these older 
animals have a greater likelihood of having been involved 
in a past major outbreak.
Figure  6 is a theoretical representation of Figure  4B, 
with serological markers presented as either pink (as a 
result of the first major outbreak following virus intro-
duction into the herd) or blue (as a result of the subse-
quent reactivation event). That is, the colours assist in 
visualising whether the serological status of the animals 
is a result of the initial introduction or a later reactiva-
tion. Virus reactivation is an important component of 
BoHV-1 dynamics, not because of the infectivity of ani-
mals undergoing secondary infection, but rather because 
of the potential for these animals to initiate further pri-
mary infections. Thus, it is reasonable when literature 
reports outbreaks induced by reactivation of the virus as 
indistinguishable from outbreaks due to new introduc-
tion of the virus from outside the herd [8].
The conceptualisation shown in Figure 6 suggests per-
fect ‘on–off’ dynamics of virus circulation. Although this 
is generally in agreement with field data as presented in 
Figure  2, several herd profiles incorporate noisy devia-
tions from the conceptually expected 0% and 100% lev-
els. There are a number of reasons why this might be 
the case. These include imperfect test characteristics of 
the ELISA or animal movements [9] highlight that with 
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large transmission values of BoHV-1 (R0 = 7), theoreti-
cally up to 15% of the virus introductions may result in 
a small outbreak (i.e. the first primary infected animals 
by chance do not affect greater parts of the herd before 
virus circulation fades off), hence, leaving noise in the 
seroprevalence of the respective age-cohorts. The results 
of a recent study in Irish dairy cattle suggest that there is 
a genetic component to BoHV-1 susceptibility, such that 
not all animals in a herd are at equal risk of seroconver-
sion [23]. Also the level of shedding can vary depending 
on the strain of the virus which may potentially explain 
some of the variation observed [3]. The introduction of 
vaccinated but uninfected animals into a non-vaccinating 
herd that tests for antibodies using a gB ELISA would 
also result in false positives and may add noisy deviations. 
We intentionally excluded herds with large numbers of 
introduced stock from the investigated data sets in order 
to minimise this issue. Nevertheless, small numbers of 
traded animals could still alter the apparent seropreva-
lence of an age-cohort. The introduction of serologi-
cally positive younger animals may add noise to the 0% 
cohorts, whereas introducing serologically negative older 
animals blurs the 100% in the respective cohorts. How-
ever, in practice that might not be a problem given that 
animal movements could be identified and excluded from 
defined age-cohorts until the profile category (red, blue, 
green in Figure 2) emerges. Introducing an animal under-
going primary infection on farm is compatible with either 
of the two scenarios in Figure  4 and “overwrites” the 
serological patterns from past virus circulation without 
the need for a reactivation event in the herd.
Both our survey data and model outputs present the 
ideal patterns of age-dependent seroprevalence profiles 
because trade of animals was excluded or suppressed. We 
are aware that in practice many herds will not be closed 
(i.e. through homebred replacement) with movements 
both into and out of the herd over several age-cohorts. 
As depicted in Figure  3A, this can result in noisier 
age-related seroprevalence profiles and may eventu-
ally blur the critical age cohort. However, modern cattle 
farming includes the recording of animal movements on 
the herd; thus, providing an effective correcting tool. The 
exclusion of introduced animals from the calculation of 
seroprevalence by age-cohort restored the predicted pro-
file and the associated age-related threshold (Figure 3B).
Our understanding of the dynamics of BoHV-1 sero-
prevalence has been greatly improved by comparing 
aggregated serological results (across herds) with an 
interpretation of outcome patterns (age-dependent sero-
prevalence). Indeed, the benefit of visualising data in 
this more complex but complete manner has been rec-
ognised previously as a more appropriate starting point 
prior to technical aggregation [38]. In the current study, 
summarizing unmatched seroprevalence data across 
herds disregards the non-synchronised occurrence of 
BoHV-1 outbreaks in different herds, with the potential 
for a misleading interpretation of the resultant patterns. 
We have demonstrated the utility of explicitly visualising 
data of age-related serological surveys according to indi-
vidual herd profiles. This approach moves the focus from 
an observation of an apparent trend across several age-
cohorts towards one immediately centred on the young-
est age cohort with seroprevalence close to 100%. Indeed, 
identification of the youngest age cohort involved in the 
last outbreak already indicated that serological profiles of 
any of the older age-cohorts in the herd will tend toward 
100% seropositivity.
In Irish dairy farming, different management groups 
(e.g. youngstock, lactating cows) often form independ-
ent epidemiological units, due to, for example, separate 
housing or grazing on separate blocks of land. There 
would be a need for an independent evaluation of sero-
prevalence profiles within each management group, if 
these were found to be epidemiologically distinct on a 
single farm. Since we were not able to extract these man-
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Figure 6 Conceptual model for the spread and temporal development of BoHV‑1 seroconversions in an unvaccinated dairy herd over 
the course of 10 years. A successful reactivation event occurred 5 years after initial virus introduction. In each of the plots, the black line represents 
apparent seroprevalence of a theoretical herd whereas pink represents seroconversions attributable to the initial outbreak and blue to the 
subsequent reactivation event. A Age‑dependent seroprevalence profile half a year after initial virus introduction; B seroprevalence profile 4.5 years 
after virus introduction; C seroprevalence profile 5.5 years after virus introduction i.e. half year after reactivation event. D Seroprevalence profile 
10 years after initial virus introduction and 5 years after the reactivation event.
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whole herd as a single epidemiological unit in our model-
ling work.
By coupling the outcome of our data analysis with sim-
ulation output of an individual-based model at the herd 
scale, we have shown that the youngest age-cohort with 
a high seroprevalence profile in a naïve herd is related to 
the time interval since infection ceased to circulate (while 
still being present in latent form in seropositive animals). 
It is intrinsic to the interpretation of age-dependent sero-
prevalence profiles that only the most recent outbreak 
can be deduced from the profile. Indeed, a successful 
reactivation event (i.e. one that initiates further primary 
infections) within the herd or the introduction of the 
virus by other pathways (that results in active virus cir-
culation) will each result in a further outbreak that will 
mask the previous serological profile (e.g. Figure 6).
Effect of vaccination
The main benefit of the age-threshold approach comes 
with longitudinal surveys tracking the progression of 
the youngest age-cohort with a seroprevalence close to 
100%. Particularly in relation to vaccination, this type of 
longitudinal view may demonstrate to stakeholders the 
efficacy of the intervention (Figure  5). In the case herd 
in this study, the data did not reveal any virus circula-
tion after the herd started vaccination. This is plausible 
according to experimental and field data from several 
studies which demonstrated that different BoHV-1 vac-
cines can effectively reduce the severity of clinical signs, 
the shedding of infectious material and, most beneficially, 
the frequency of reactivation [8, 11, 37, 39]. Replacement 
of old seropositive stock by seronegative home-bred 
young-stock led to a continual shift of the age-threshold 
of the seroprevalence profile towards older animals con-
firming the absence of another major episode of virus cir-
culation since vaccination was commenced. This pattern 
was observed also in other vaccinating herds with mini-
mal in-moves (see Additional file 3).
Intrinsic to the interpretation of age-dependent sero-
prevalence profiles (see Figure  5), it is not possible to 
conclude whether there has been more than one major 
outbreak in a herd or what the timing was between these 
outbreaks. Logically therefore, an equivalent shift in the 
age-threshold in the seroprevalence profile would appear 
if reactivation events or external introduction of virus 
(for example through contamination of people or equip-
ment, or buying-in of animals with primary infections) 
had not occurred since 2011, irrespective of whether the 
herd had been vaccinated or not (see Figure  2). There-
fore, we cannot directly attribute the dynamics in Fig-
ure  5 to the effectiveness of the vaccine. An identified 
exposure to BoHV-1 subsequent to the introduction of 
vaccination is needed in order to demonstrate that vac-
cination was protecting this herd from further major out-
breaks. A single seroconversion due to field infection in 
age-cohorts younger than the age-threshold would pro-
vide evidence of herd challenge and protective effect of 
herd vaccination.
Nevertheless, the longitudinal pattern shown in Fig-
ure 5 gives a picture of how the effect of vaccination on 
the epidemiology of age-related BoHV-1 prevalence can 
be investigated in future research and surveillance. Con-
sistent vaccination is cited as the main factor in reduc-
ing prevalence in countries with high seroprevalence and 
is therefore suggested as an essential tool at the start of 
eradication programmes [1].
Implications for herd testing and virus control
We have elaborated how age-related seroprevalence 
improves the understanding of output-related patterns 
of serological data regarding BoHV-1 infection. Given 
our intention to provide decision support for the design 
and implementation of effective control measures, this 
improved understanding can be translated to recommen-
dations to make the best use of testing and vaccination. 
Age-related serological data, as used at individual herd 
level in our study, can indicate whether BoHV-1 infection 
was recently circulating in a herd (red in Figure 2) or only 
in the past (blue in Figure  2). The identified categorisa-
tion supports the interpretation of the BoHV-1 related 
status of a herd and is more informative than considering 
changes in the overall herd seroprevalence level.
The conceptual understanding of a critical age-thresh-
old per individual herd in a serological survey translates 
into alternative testing strategies to address different 
questions (see Table 1). First, to inform a screening sur-
vey targeting the presence of BoHV-1 in a population, 
the most reliable source are older age-cohorts. Second, 
Table 1 Derived implications for herd testing and surveillance. 
Surveillance objective Proposed approach
Detection of BoHV‑1 antibodies in a population Concentrate test capacity on older age‑cohorts
Detection of recent BoHV‑1 circulation in a population Concentrate test capacity on the youngest age‑cohort without maternal immunity but 
with epidemiological contact with older latently infected animals
Monitor efficiency of vaccination and other control measures Observe the annual increase in the age of the age‑threshold cohort based on the 
seroprevalence profile
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the most informative source for serological surveillance 
of recent BoHV-1 circulation would be the youngest age-
class in a herd that excludes interference with maternal 
immunity and has epidemiological contact with older 
latently infected animals. Third, in order to monitor effi-
ciency of vaccination and associated control measures, 
the annual increase in the age-threshold of the sero-
prevalence profile would be supported by surveillance 
of potential new exposure via the testing in younger age-
cohorts. For dairy herds, screening of first lactation ani-
mals would be a useful tool to confirm that BoHV-1 did 
not continue to circulate.
Conclusion
We confirm an age-related trend in the prevalence of 
BoHV-1 antibodies. On average, older animals are more 
often seropositive than youngstock. However, analysis 
of individual herd profiles has demonstrated that major 
BoHV-1 outbreaks in dairy cattle herds affect animals 
independent of age and lead to almost 100% seroconver-
sion in all age groups, or at least in all animals within a 
single epidemiological unit. Herds were identified whose 
seroprevalence profiles showed steep jumps between 
consecutive age cohorts, from a low to very high per-
centage of seropositive animals. The age-cohort in which 
this steep jump occurs will shift with every year without 
a new major outbreak and provide information on the 
BoHV-1 status and history of the herd. Therefore, it is 
useful to evaluate age-related data from serological sur-
veys to identify the age-threshold cohort (the youngest 
age cohort with seroprevalence close to 100%) in each 
herd. This age-threshold cohort provides useful informa-
tion for surveillance and monitoring. Population-based 
screening of BoHV-1 herd-level prevalence should tar-
get the older age-cohorts, whereas detection of recent 
virus circulation (i.e. major outbreaks) should address the 
youngest age-cohorts in a herd without maternal immu-
nity but with epidemiological contact with older latently 
infected animals. Efficacy of vaccination or other inter-
vention strategies (e.g. biosecurity) should be monitored 
by observing the longitudinal shift in the age of the age-
threshold cohort and through surveillance of the younger 
cohorts to identify potential new exposure. Further 
research is needed to explore data for seasonal calving 
beef herds to see if patterns there are as clear as in dairy 
herds.
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